MedPath

Evaluation of the Clinical, Neuropsychological and Psychosocial Situation of Patient With Eating Disorders.

Not Applicable
Conditions
Eating Disorders
Interventions
Other: Clinical assessment
Registration Number
NCT02829645
Lead Sponsor
University Hospital, Montpellier
Brief Summary

Eating disorders (ED) are serious mental illnesses with an excess mortality and many affects in the quality of life of patients and thier relatives. Management of ED is very difficult : the prognosis remains relatively poor both in terms of remission rate and quality of life. In this context, the contribution of new strategies for pathophysiological exploration and the development of therapeutic options are crucial.

In this project the investigators aim to constitute un cohort of patients from a day unit specialized in the management of ED. A prospective follow-up will be offered to patients to assess their clinical and psycho-social evolution. The overall objective is to identify which factors are prognostic of clinical improvement of the ED. We also want to better characterize patients that will migrate from diagnosis to another.

Detailed Description

The investigators propose to assess, with a cohort of patients with ED the prognostic value of cognitive abnormalities associated with ED (cognitive flexibility and central coherence) They will recruit 370 patients suffering from a current ED (anorexia, bulimia, binge eating disorder, Eating disorder not otherwise specified).

Each patient will be reassessed every year for 3 years.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
370
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Eating disordersClinical assessment-
Primary Outcome Measures
NameTimeMethod
Frequency of remission ratesAt the inclusion and at 12, 24 and 36 months

study of remission rates frequency at 12 months depending on the Brixton score assessed at baseline (assessment of cognitive flexibility). Remission is defined as disappearance of ED Diagnostic and Statistical Manual (DSM) criteria.

Secondary Outcome Measures
NameTimeMethod
score to another neuropsychological test (Iowa gambling task (IGT)At the inclusion and at 12, 24 and 36 months

Study of remission rates frequency at 12 months depending on the IGT score (decision making) assessed at baseline

scores to another neuropsychological test : D2 test of attentionAt the inclusion and at 12, 24 and 36 months

Study of remission rates frequency at 12 months depending on the D2 test (attention) assessed at baseline

scores to another other neuropsychological test : Rey-Osterrieth complex figureAt the inclusion and at 12, 24 and 36 months

Study of remission rates frequency at 12 months depending on the Rey figure assessed at baseline

© Copyright 2025. All Rights Reserved by MedPath